Bahar Özmen Şentürk

Bahar Özmen Şentürk

Auto-generated profile, based on publicly available information

Bahar Özmen Şentürk

Istanbul University, Istanbul Faculty of Medicine, Clinical Nutrition Team, Istanbul Faculty of Medicine, Fatih, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2019 in Clinical Science of Nutrition
Verified
Journal Article
Closed access
MÇMukadder Levent Çelik
Mukadder Levent Çelik
SÇSuzan Çelik
Suzan Çelik
BŞBahar Özmen Şentürk
Bahar Özmen Şentürk
SBSerpil Büyükdemir
Serpil Büyükdemir
TATimur Selçuk Akpınar
Timur Selçuk Akpınar
BSBulent Saka
Bulent Saka
Objective: Cardiac cachexia (CC) is defined as a loss of at least 6% of total body weight in 6 months due to chronic heart failure (CHF). The prevalence of CC in patients with NYHA class II-IV is estimated to be approximately 12%-15%. There are only a few studies that demonstrate the effects of malnutrition treatment on nutrition, physical activity, quality of life (QoL), and clinical course of the disease. This study aimed to evaluate the effect of nutrition treatment on anthropometric measurements, fat free mass (FFM), muscle strength, physical performance, and QoL together with cardiac functions and immunity in patients with CC. Method: This was a prospective clinical intervention study. Patients with NYHA stage II-IV CHF (n=725) followed-up in Internal Medicine and Cardiology Departments were screened for CC. Eighteen patients with CC were enrolled in the study. The control group included 18 healthy adults. Nutritional status assessment, anthropometric measurements, gait speed, muscle strength, bioelectrical impedance analysis (BIA Tanita, Japan), biochemical analyses, and cytokine measurements were performed. Cardiac functions were assessed by echocardiography. Nutrition support treatment was given to patients with CC, and they were followed-up for next 3 months. QoL was measured with “Ferrans and Powers” Quality of Life Index (cardiac version). Similar studies were repeated after follow-up. Results: After excluding all other reasons for cachexia, the prevalence of CC was 2.5% in our patients with CHF. The patients with CC had higher serum C-Reactive Protein (CRP) and IL-6 levels than the healthy controls. After nutrition support treatment, the QoL scores and visceral fat level significantly increased in patients with CC. Although mid-upper arm circumference (MUAC), handgrip strength, FFM, fat mass, and serum albumin levels increased, they were not statistically significant. Conclusion: When compared to previous studies, our CC prevalence rate was lower. Nutrition support therapy can reverse weight loss in patients with CC, which can also improve QoL. An important limitation to the study is the low number of patients that is related with the exclusion criteria regarding every type of inflammatory disease, acute medical problems, and cancer. Therefore, further studies with more patients are needed.

11 April 2022 in Nutrition
Verified
Journal Article
Closed access
BSBulent Saka
Bulent Saka
MBMurat Bektas
Murat Bektas
OBOguz Kagan Bakkaloglu
Oguz Kagan Bakkaloglu
SAShirkhan Amikishiyev
Shirkhan Amikishiyev
GSGöktug Sarıbeyliler
Göktug Sarıbeyliler
TATimur Selcuk Akpınar
Timur Selcuk Akpınar

15 April 2020 in Clinical Science of Nutrition
Verified
Journal Article
Closed access
ABAhmet Bahar
Ahmet Bahar
BŞBahar Özmen Şentürk
Bahar Özmen Şentürk
SBSerpil Büyükdemir
Serpil Büyükdemir
GKGizem Kutlutürk
Gizem Kutlutürk
ZMZeynep Nihan Mutlu
Zeynep Nihan Mutlu
BSBulent Saka
Bulent Saka